Incontinence: A Nutrition and Natural-Health Reference
1. Definition and Overview
Urinary incontinence (UI), defined by the International Continence Society as "the complaint of any involuntary leakage of urine," is a common and distressing medical condition that severely affects quality of life. Incontinence can affect both men and women in any age group but is more common in women and the elderly. In middle-aged women, prevalence estimates range from 30% to 40%, and rise to about 50% in older women.
Normal urinary continence and bladder control requires a complex interaction between the brain, nervous system, and organs in the pelvis. The pelvic organs include the bladder, urethra, the prostate in men, and the muscles of the pelvic floor called the levator ani. The brain receives messages from the filling bladder and sends messages to the bladder to keep it from automatically emptying until an appropriate time; failures in this control mechanism result in incontinence.
As the population ages, the number of people suffering from bladder control problems is increasing. The costs of this problem are personal, physical, and financial, and many with incontinence suffer social embarrassment, isolation, ill health, and even depression.
2. Types and Clinical Presentation
There are five basic types of incontinence: stress incontinence, urge incontinence, mixed incontinence, overflow incontinence, and functional incontinence.
- Stress Urinary Incontinence (SUI): The involuntary loss of urine that occurs due to sudden increases in intra-abdominal pressure resulting from activities such as coughing, sneezing, lifting, straining, exercise, and in severe cases, even simply changing body position. Stress incontinence occurs when the urethral sphincter, the pelvic floor muscles, or both these structures have been weakened or damaged and cannot dependably hold in urine.
- Urge Urinary Incontinence (UUI) / Overactive Bladder: A sudden, involuntary contraction of the bladder's muscular wall causes an urge to urinate that will not stop; when the urge comes, the person has a very short time before the urine is released, regardless of what they try to do. It is often found in people who have conditions such as diabetes, stroke, dementia, Parkinson's disease, and multiple sclerosis.
- Mixed Incontinence: Inappropriate bladder contractions and weakened sphincter muscles usually cause this type of incontinence, which is a combination of the symptoms for both stress and urge incontinence.
- Overflow Incontinence: A constant dripping or leakage of urine caused by an overfilled bladder. This is more common in men with prostate gland problems, a damaged bladder, or a blocked urethra; an enlarged prostate gland can obstruct the bladder.
- Functional Incontinence: Urine escapes because a person cannot reach the bathroom in time, possibly due to a mobility issue. This type is more prevalent among elderly people and is common in nursing homes.
In terms of global distribution, the most common cause of UI is stress (50%), then mixed (32%), and finally urge (14%). Risk factors identified across populations include parity, obesity, chronic cough, depression, poor health, lower urinary tract symptoms, previous hysterectomy, and stroke.
3. Body Systems Involved
Urinary continence depends on the coordinated function of multiple physiological systems:
- Urinary tract: The urinary system consists of many different organs that work together to filter, store, and remove waste from the body as urine.
- Nervous system: Bladder muscles can activate involuntarily because of damage to the bladder's nerves, nervous system, or muscles.
- Pelvic floor musculature: Pelvic floor muscle training is a method of improving urinary and fecal incontinence by strengthening the contractile force of the pelvic floor muscles, such as the external anal sphincter and levator ani muscles.
- Endocrine system: Hormonal imbalance may also cause or contribute to incontinence.
- Smooth muscle: Magnesium acts as a natural calcium antagonist, inhibiting voltage-gated calcium channels and reducing detrusor muscle overactivity, underscoring the role of calcium signaling in bladder smooth muscle physiology.
4. Contributing and Associated Factors
4.1 Demographic and Reproductive Factors
Increased age, body mass index, parity, current smoking, type 2 diabetes mellitus, and hysterectomy all were positively associated with incontinence in a large cross-sectional analysis of over 83,000 nurses. This cross-sectional analysis of 83,355 Nurses' Health Study II participants concluded that urinary incontinence is highly prevalent among middle-aged women, with potential risk factors including age, race/ethnicity, body mass index, parity, smoking, diabetes, and hysterectomy.
Obstetrical factors associated with UI include high parity, young age at first childbirth, forceps delivery, and prolonged labor. Vaginal parturitions and neonates with a weight exceeding 4 kg serve as significant risk factors for postpartum urinary incontinence, while cesarean delivery emerged as a protective factor.
4.2 Obesity and Metabolic Disease
Observational studies suggest that obesity is a strong risk factor for urinary incontinence, and preliminary studies suggest that weight loss may have a beneficial effect on urinary incontinence in obese patients. Intra-abdominal pressure at maximum cystometric capacity increases with rising BMI, suggesting a direct mechanical mechanism by which adiposity stresses the bladder and sphincter. In older men, the top risk factors include increasing/advanced age, benign prostatic hyperplasia (BPH), diabetes mellitus, detrusor overactivity, limitation in physical function/ADL disability, increased BMI/overweight/obesity, dementia, and Parkinson's disease.
4.3 Constipation and Chronic Pressure
Chronic constipation, chronic cough, and history of urinary tract infection were identified as predictors of UI in regression analysis. Straining from constipation or lots of coughing are among the factors that can weaken pelvic floor muscles over time.
4.4 Neurological Comorbidities
Urge incontinence is often associated with conditions such as diabetes, stroke, dementia, Parkinson's disease, and multiple sclerosis. The physical examination looks for signs of medical conditions causing incontinence, such as tumors that block the urinary tract, stool impaction, and poor reflexes or sensations, which may be evidence of a nerve-related cause.
5. Nutrients Studied in Relation to Incontinence
5.1 Magnesium
Proposed mechanism: Given magnesium's critical role in muscle regulation and nerve function, its deficiency may contribute to the pathophysiology of UI. Emerging evidence suggests that magnesium deficiency may contribute to UI through its role in smooth muscle regulation; magnesium acts as a natural calcium antagonist, inhibiting voltage-gated calcium channels and reducing detrusor muscle overactivity.
Scientific Evidence: In a prospective, randomized, double-blind, placebo-controlled study, 40 women with sensory urgency or detrusor instability received either magnesium hydroxide or placebo. Pre- and post-treatment symptoms, frequency-volume charts, and cystometry results were compared. Eleven of 20 patients receiving magnesium (55%) reported a subjective improvement of their urinary symptoms, compared with five patients taking placebo (20%). In both study groups, however, there was no statistically significant difference in pre- and post-treatment urodynamic parameters in those reporting symptomatic improvement. Magnesium was well tolerated, and these results suggest it may be beneficial for detrusor instability or sensory urgency in women. This was a small, preliminary trial; larger confirmatory studies have not yet been conducted.
Clinical trials have shown that magnesium supplementation alleviates postoperative bladder discomfort and improves urgency symptoms in women with detrusor instability. A national survey analysis found higher magnesium depletion scores in individuals with UI, with more severe symptoms as magnesium levels decreased, underscoring the importance of magnesium deficiency in UI. Overall, the clinical evidence base for oral magnesium supplementation in UI is limited by the small number and small size of trials; findings are preliminary.
5.2 Vitamin D
Proposed mechanism: The possible effect of vitamin D on the detrusor muscle and on the levator ani muscles β which contain both smooth and striated muscle fibers β could explain the association between vitamin D deficiency and urinary incontinence. Previous studies have demonstrated that a vitamin D receptor agonist can regulate calcium entry through L-type CaΒ²βΊ channels in the human bladder smooth muscle cells, suggesting a possible effect on the modulation of bladder contractile mechanisms.
Epidemiological associations: There is increasing evidence suggesting that vitamin D deficiency or insufficiency is associated with lower urinary tract symptoms. Data from a large national health survey found that men with vitamin D levels below 50 nmol/L had roughly 68% higher odds of stress urinary incontinence and 82% higher odds of mixed urinary incontinence compared to men with sufficient levels (75 nmol/L or above).
Clinical trial evidence: A systematic review and meta-analysis following PRISMA guidelines, registered in PROSPERO (CRD42024531716), searched databases including PubMed and Scopus for randomized controlled trials involving adults with confirmed UI. Four RCTs from Iran, the UK, and Turkey (2019β2023), comprising 263 participants, were included. The meta-analysis on vitamin D's impact on UI severity initially showed a non-significant reduction, but sensitivity analysis revealed a significant reduction; further analysis demonstrated significant reductions with 50,000-unit weekly vitamin D versus placebo. Vitamin D supplementation has been shown to enhance treatment satisfaction, improve quality of life for patients with UI, and reduce disease severity. There is compelling evidence supporting the significant association between oral vitamin D supplementation and the treatment of UI; however, notable heterogeneity among studies highlights the need for further research before clinical approval for high-dose vitamin D supplementation can be recommended. The evidence is therefore promising but not yet conclusive due to the small number of trials and high heterogeneity.
5.3 Soy Isoflavones
Proposed mechanism and preclinical evidence: Laboratory studies show that daidzein, a phytoestrogen found in soy, increases the growth of connective tissue cells around the urethra. In animal studies, long-term soy-enriched diets increased the contractile strength of the bladder muscle and improved urethral closure pressure compared to controls, and a soy diet also counteracted age-related declines in bladder muscle activity. In a rodent study, soy isoflavone replacement improved detrusor overactivity with alteration of the connexin-43 expression pattern in the urinary bladder of ovariectomized rats; routine consumption of dietary soy isoflavones may be a useful intervention to prevent and improve overactive bladder. This is animal and in-vitro evidence only; the clinical relevance in humans requires further study.
Use in clinical products: Although pumpkin seeds became known worldwide owing to traditional use, recent scientific evidence for their effects is scarce. The use of soy isoflavones is well documented for several indications related to hormonal imbalances. A randomized, double-blind, placebo-controlled study evaluated efficacy and safety of a product combining pumpkin seed and soy germ extracts in 120 subjects suffering from overactive bladder. The combination product, rather than soy isoflavones in isolation, has been the focus of most human trials to date.
6. Herbs and Natural Ingredients Studied in Relation to Incontinence
6.1 Pumpkin Seed (Cucurbita pepo)
Traditional use: Pumpkin (Cucurbita) seeds are traditionally known around the world for their remedial effects on urinary tract complications, such as nocturia, urinary frequency, and stress urinary incontinence. Seeds from the medicinal pumpkin, Cucurbita pepo, are officially monographed for the use with irritable bladder symptoms and micturition problems of benign prostatic hyperplasia (BPH) stages 1 and 2 (ESCOP monograph, 2009).
Proposed constituents: Cucurbita pepo seed oil consists of high amounts of free fatty acids, serving as a natural source of vitamins, proteins, trace elements, and polyunsaturated fatty acids. It is the phytosterol content of Cucurbita pepo seed oil that appears to interfere with the function of dihydrotestosterone produced by 5Ξ±-reductase, which plays a major role in the process of BPH.
Scientific evidence: Studies performed in the past showed that a premixed blend of pumpkin seed extract and soy germ extract was able to improve urinary incontinence as well as BPH-related symptoms in different populations; however, the limitation of these studies was the fact that they were not placebo-controlled.
A randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of a combination of pumpkin seed extract and soy germ extract in 120 subjects suffering from overactive bladder. The treatment group experienced significant reductions in urination frequency, urgency, incontinence episodes, and nighttime trips to the bathroom over 12 weeks. A 12-week randomized trial using a pumpkin seed extract (Cucurbita pepo) and a proprietary soy germ extract (Glycine max) combination showed no significance in reducing incontinence specifically. Results across trials are therefore mixed, and the overall evidence base is preliminary, limited by small sample sizes and the use of combination products rather than isolated extracts.
Although the results of pumpkin seed oil studies are preliminary and further study is needed, they suggest that pumpkin seed oil extracted from C. maxima has the potential for prevention or treatment of urinary disorders including overactive bladder.
6.2 Gosha-Jinki-Gan (GJG)
Traditional use: Gosha-jinki-gan (GJG) is a traditional Chinese blended herbal medicine composed of 10 different herbs. Ancient peoples have historically required treatments for urinary urgency, urinary frequency, nocturia, and urgent incontinence; traditional Chinese medicine (TCM) has been developed in China over thousands of years, and some regimens and single-herb medicines have been demonstrated to manage such overactive bladder symptoms.
Preclinical evidence: Bladder contraction mediated by pelvic nerve stimulation and induced by acetylcholine administration was significantly inhibited by administration of 100 mg/kg GJG in anesthetized dogs; effects were similar to that seen with atropine administered at 0.1 mg. Gosha-jinki-gan may prevent the bladder urothelium from increasing expression of tachykinins and TRPV1 and P2X3 receptors during stimulation in rats, and may decrease expression of transmitter proteins and sensory receptors without destroying nerve fibers.
Human clinical evidence: In a study evaluating GJG's clinical efficacy, 30 elderly male patients with overactive bladder received 2.5 g GJG three times daily. After 6 weeks of treatment, significant improvements were observed in International Prostate Symptom Score, overactive bladder symptom score, and quality of life score; GJG was significantly effective in improving urgency, micturition frequency, nocturia, and urinary incontinence.
In a separate study, the efficacy and tolerability of 7.5 g/day GJG were analyzed in 44 Japanese females diagnosed with overactive bladder. The total scores of International Prostate Symptom Score, quality of life index scores, and urinary frequency during daytime and sleep were significantly decreased. Objective evaluation yielded improvement in 46% and excellent results in 7%.
The medical literature primarily documents the use of gosha-jinki-gan in treating overactive bladder and diabetes; however, data from quality clinical trials are lacking to support these uses. Most clinical studies utilized a dosage range of 4.5 to 7.5 g/day. The existing evidence is predominantly from small, uncontrolled, or non-randomized studies, predominantly in Japanese populations, and the overall quality of evidence is considered low.
6.3 Hachi-Mi-Jio-Gan
Traditional use: Hachi-mi-jio-gan is a Chinese herbal formulation that is traditionally used to lower bladder contractions, thus reducing the need to urinate.
Scientific evidence: The Chinese herbal blend hachi-mi-jio-gan contains several of the same herbs found in gosha-jinki-gan and may inhibit bladder contractions prompted by the chemical acetylcholine, according to a Japanese study done on rats. No human trials have been conducted. The evidence is therefore limited to animal/preclinical data.
6.4 Buchu (Barosma betulina)
Traditional use: Buchu (Barosma betulina), found in the mountains of South Africa, has been used as medicine since the 1650s. This flowering plant, native to the mountainous areas of South Africa, has a long history of traditional use; legend has it that buchu helps heal everything from fevers to coughs to urinary tract infections.
Scientific evidence: No studies measure buchu's effect on overactive bladder or urinary incontinence. Its use in this context rests entirely on traditional practice with no verified clinical evidence.
6.5 Corn Silk (Zea mays)
Traditional use: Corn silk contains vitamins and antioxidants and has been used to treat urinary tract infections for centuries; more recently it has become a traditional treatment for overactive bladder, but there is no research showing how well it works.
Scientific evidence: Corn silk tea is said to ease urinary tract infection symptoms, but no data backs up that claim; nor is there scientific proof that corn silk would help overactive bladder.
6.6 Ganoderma lucidum (Reishi Mushroom)
Traditional use: For 2,000 years, this mushroom has been a staple of Chinese medicine.
Scientific evidence: A Japanese study showed it lowered the urge to void after 8 weeks; researchers think it lowers levels of hormones that boost prostate growth β one cause of overactive bladder in men. The evidence is preliminary and derives from a single small study; replication in rigorous controlled trials is lacking.
7. Dietary and Lifestyle Factors
7.1 Weight and Body Mass Index
Participants in the Program to Reduce Incontinence by Diet and Exercise (PRIDE) experienced both significant weight loss and a significant reduction in the frequency of their incontinence episodes. The study randomly assigned 338 overweight and obese women with at least 10 urinary-incontinence episodes per week to an intensive 6-month weight-loss program that included diet, exercise, and behavior modification, or to a structured education program. Published in the New England Journal of Medicine in 2009, the PRIDE trial is among the strongest available evidence linking weight reduction to incontinence improvement in overweight and obese women. Considering the PRIDE results and other health benefits, the initiation of weight loss has been advocated as a first-line intervention in overweight and obese women with urinary incontinence.
7.2 Caffeine
In addition to fluid intake, there is some evidence to support a role of caffeine, alcohol, and carbonated beverages in the pathogenesis of overactive bladder and lower urinary tract dysfunction. Frequency was assessed in five studies, which showed that decreasing caffeine and fluid intake was effective in treating the symptom. Urinary incontinence episodes were assessed in six studies; restricting caffeine intake was effective in treating these symptoms, but restricting both caffeine and fluid intake simultaneously was not. Although evidence is limited, available systematic review data provide scientific evidence that fluid and caffeine intake modification effectively manages overactive bladder symptoms; further research should examine acceptability and sustainability of interventions in the long term.
7.3 Fluid Intake
Fluid intake is known to affect lower urinary tract function, though the effects of caffeine, carbonated drinks, and artificial sweeteners are less well understood. Given the available evidence, lifestyle interventions and fluid modification may have an important role in the primary prevention of lower urinary tract symptoms. However, more research is needed to determine the precise role of caffeine, carbonated drinks, and alcohol in the pathogenesis and management of these symptoms.
7.4 Alcohol
Diet, fluid intake, and caffeine, alcohol, and tobacco use may have effects on lower urinary tract symptoms. Constructive changes in these modifiable, non-urological factors are suggested to improve lower urinary tract symptoms, according to a systematic review published in the Journal of Urology. The quality and consistency of evidence for alcohol specifically remains modest, and large well-controlled trials are still needed.
7.5 Pelvic Floor Muscle Training (Kegel Exercises)
Kegel exercises, also called pelvic floor muscle training, are simple exercises used to treat bladder problems and improve bowel control. They strengthen the pelvic floor muscles that support the bladder, rectum, and uterus β muscles that stretch like a hammock from the front to the back of the pelvis and can help prevent releasing urine, stool, or gas at the wrong times. Many factors, including pregnancy and childbirth, surgery, and aging, can weaken pelvic floor muscles; if these muscles are weak, small amounts of urine, stool, or gas may leak. Kegel exercises strengthen these muscles, helping stop these leaks; studies suggest that pelvic floor muscle training may also improve sexual function.
The Cochrane Database of Systematic Reviews (Dumoulin et al., 2018, CD005654) is cited in NIDDK guidance as foundational support for pelvic floor muscle training in women with urinary incontinence. If done regularly, results can be expected within a few weeks to a few months β for example, leaking urine less often β and to keep getting benefits from Kegels, these exercises should become a lasting part of the daily routine.
7.6 Dietary Fiber and Constipation Management
Potential risk factors for UI include constipation and chronic respiratory problems alongside more commonly studied factors. Since constipation creates chronic pelvic floor straining, straining from constipation or lots of coughing is recognized as a mechanism that weakens pelvic floor integrity over time. Adequate dietary fiber intake to maintain regular bowel habits is therefore discussed in the context of pelvic floor preservation, though specific clinical trials targeting fiber as a direct incontinence intervention are limited.
7.7 Physical Activity
Other than childbirth, modifiable non-obstetrical risk factors for pelvic floor disorders pertinent to reproductive-aged women include obesity, lifestyle factors, constipation, and physical activity. The interplay between exercise type, pelvic floor loading, and incontinence risk is complex: high-impact activities may increase intra-abdominal pressure acutely, while regular moderate activity combined with pelvic floor training is generally regarded favorably in the literature.
8. Fecal Incontinence: Specific Dietary Considerations
Fecal incontinence involves the involuntary loss of stool and shares many pelvic floor mechanisms with urinary incontinence. Pelvic floor muscle training is a method of improving both urinary and fecal incontinence by strengthening the contractile force of the pelvic floor muscles, such as the external anal sphincter and levator ani muscles. Dietary fiber has been specifically examined in fecal incontinence: a randomized clinical trial by Bliss et al. (2014, Research in Nursing & Health 37:367β378) investigated dietary fiber supplementation for fecal incontinence; a further trial by Lauti et al. (2008, Colorectal Disease 10:553β562) examined fiber supplementation in addition to loperamide for fecal incontinence in adults. These trials, referenced in published systematic reviews, indicate that fiber modification may reduce fecal incontinence episodes by normalizing stool consistency and transit.
9. Summary of Evidence Strength
- Strong / Well-established: Pelvic floor muscle training (Kegel exercises) β supported by Cochrane systematic review (Dumoulin et al., 2018); weight loss in obese/overweight women β supported by the PRIDE randomized controlled trial (NEJM, 2009); caffeine reduction β supported by multiple controlled studies in systematic review.
- Moderate / Promising but limited: Vitamin D supplementation β four RCTs meta-analyzed; significant findings in sensitivity analysis but notable heterogeneity. Pumpkin seed extract β single pivotal RCT of 120 participants with mixed results across outcomes.
- Preliminary / Small studies: Magnesium supplementation β one small double-blind RCT (n=40) with subjective but not urodynamic significance; national survey epidemiological data supporting the association.
- Preclinical/Animal only: Soy isoflavones (isolated); hachi-mi-jio-gan for bladder; ganoderma (one small clinical study without rigorous controls).
- Traditional use only, no clinical evidence: Buchu (Barosma betulina), corn silk (Zea mays), horsetail (Equisetum).
References
Go back